+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model



Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model



Neoplasia 9(7): 546-555



Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely used to evaluate tumor permeability, yet measurements have not been directly validated in brain tumors. Our purpose was to compare estimates of forward leakage K(trans) derived from DCE-MRI to the estimates K obtained using [(14)C]aminoisobutyric acid quantitative autoradiography ([(14)C]AIB QAR), an established method of evaluating blood-tumor barrier permeability. Both DCE-MRI and [(14)C]AIB QAR were performed in five rats 9 to 11 days following tumor implantation. K(trans) in the tumor was estimated from DCE-MRI using the threeparameter general kinetic model and a measured vascular input function. K(i) was estimated from QAR data using regions of interest (ROI) closely corresponding to those used to estimate K(trans). K(trans) and K(i) correlated with each other for two independent sets of central tumor ROI (R = 0.905, P = .035; R = 0.933, P = .021). In an additional six rats, K(trans) was estimated on two occasions to show reproducibility (intraclass coefficient = 0.9993; coefficient of variance = 6.07%). In vivo blood-tumor permeability parameters derived from DCE-MRI are reproducible and correlate with the gold standard for quantifying blood tumor barrier permeability, [(14)C]AIB QAR.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 017626579

Download citation: RISBibTeXText

PMID: 17710157

DOI: 10.1593/neo.07289


Related references

The effect of AMG 706, a novel multi-kinase inhibitor, on vascular permeability and blood flow as assessed by dynamic contrast enhanced magnetic resonance imaging in an in vivo preclinical tumor model. Journal of Clinical Oncology 23(16_Suppl): 3134-3134, 2016

Blood-brain barrier permeability measured using dynamic contrast-enhanced magnetic resonance imaging: a validation study. Journal of Physiology 597(3): 699-709, 2019

The vascular permeability and the extent of the extracellular space as determined by dynamic contrast-enhanced magnetic resonance imaging is associated with tumor oxygenation and vascular density in cancers of the uterine cervix. Gynecologic Oncology 72(3): 493-494, 1999

Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping. Investigative Radiology 46(10): 624-631, 2011

The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging. Clinical Cancer Research 11(2 Pt 1): 529-536, 2005

Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. International Journal of Radiation Oncology Biology Physics 82(3): E537-E544, 2012

Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging. Oncology Letters 14(5): 5418-5426, 2017

Tumor permeability of nanocarriers observed by dynamic contrast-enhanced magnetic resonance imaging. Yakugaku Zasshi 130(12): 1679-1685, 2010

Permeability and blood volume measurements in intracranial 9L rat glioma using dynamic contrast-enhanced magnetic resonance imaging. Society for Neuroscience Abstracts 22(1-3): 950, 1996

Quantitative assessment of tumor responses after radiation therapy in a DLD-1 colon cancer mouse model using serial dynamic contrast-enhanced magnetic resonance imaging. Yonsei Medical Journal 53(6): 1147-1153, 2012

Measurements of capillary permeability on brain tumors using contrast-enhanced magnetic resonance imaging. Nichidai Igaku Zasshi 62(10): 529-537, 2003

Application of Dynamic Contrast Enhanced Magnetic Resonance Imaging to Evaluate Angiogenic Response and Vascular Permeability. Arteriosclerosis, Thrombosis, and Vascular Biology 39(8): 1507-1509, 2019

Using semi-quantitative dynamic contrast-enhanced magnetic resonance imaging parameters to evaluate tumor hypoxia: a preclinical feasibility study in a maxillofacial VX2 rabbit model. American Journal of Translational Research 7(3): 535-547, 2015

Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clinical Cancer Research 13(12): 3449-3459, 2007

Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist. Bjr Case Reports 3(3): 20160099, 2017